Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED COMPENSATION (Tables)

v3.24.1.1.u2
SHARE BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2024
SHARE-BASED COMPENSATION  
Summary of components of share-based compensation expense

​

​

​

​

​

​

​

​

​

    

Three-Month Periods Ended March 31,

($’s in thousands)

    

2024

    

2023

Research and development

​

$

145

​

$

33

Selling, general and administrative

​

 

1,261

​

 

613

Total non-cash compensation expense related to share-based compensation included in operating expense

​

$

1,406

​

$

646

Schedule of stock option activities

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

    

​

    

Weighted

    

​

    

average

​

​

Number

​

average

​

Aggregate

​

remaining

​

​

of

​

exercise

​

intrinsic

​

contractual 

​

    

Shares

    

price

    

value

    

life (years)

Outstanding options at December 31, 2023

​

2,769,869

​

$

1.49

​

$

6,053,833

​

4.53

Granted

​

25,000

​

​

4.57

​

​

—

​

—

Exercised

​

(55,375)

​

​

1.22

​

​

—

​

—

Forfeited

​

(65,523)

​

​

2.91

​

​

—

​

—

Expired

​

(1,250)

​

​

2.62

​

​

—

​

—

Outstanding options at March 31, 2024

 

2,672,721

​

$

1.49

​

$

5,866,003

 

4.23

Options vested and exercisable at March 31, 2024

 

1,991,507

​

$

0.97

​

$

5,393,973

 

2.73

Schedule of restricted stock units

​

​

​

​

​

​

​

​

    

​

​

​

​

​

​

​

​

Weighted

​

​

Number of

​

average grant

​

    

units

    

date Fair value

Unvested balance at December 31, 2023

 

1,306,923

​

$

3.88

Granted

 

887,500

​

 

4.97

Vested

​

(211,028)

​

​

3.58

Forfeited

​

(10,000)

​

​

5.02

Unvested balance at March 31, 2024

​

1,973,395

​

$

4.40